Silo Pharma Inc. logo

Silo Pharma Inc.

SILO | NASDAQ
Chart Builder DCF Calculator
$1.23
-$0.02 (-1.60%)
At close: Oct 30, 2026, 4:00 PM ET
$1.23
$0.00 (0.00%)
After-hours: Oct 30, 2026, 4:00 PM ET

Market Data

Market Cap
$1.39M
Enterprise Value
$-4.04M
Beta
0.75
Average Volume
166.35K
Shares Outstanding (Diluted)
1.1M
Shares Change YoY
162.4%
Institutional Ownership
0.02%
Exchange
NASDAQ
ISIN
US82711P3001

Price Performance

Price Change 1M
-18.5%
Price Change 3M
-70.6%
Price Change 6M
-82.0%
Price Change YTD
-75.9%
Price Change 1Y
-84.8%
Price Change 3Y
-94.6%
Price Change 5Y
-99.2%
1M CAGR (ann.)
-33.1%
1Y CAGR (ann.)
-84.8%
5Y CAGR (ann.)
-61.1%
All-Time CAGR
-60.3%

Valuation

PE Ratio
-0.23
Forward PE
N/A
PEG Ratio
-0.00
Forward PEG
-0.08
PS Ratio
25.67
Forward PS
19.30
PB Ratio
0.28
P/FCF Ratio
-0.42
P/Adj. FCF Ratio
-0.40
P/OCF Ratio
-0.40
EV/Sales
-74.79
EV/EBIT
0.88
EV/EBITDA
0.88
EV/FCF
1.21
Earnings Yield
-435.0%
FCF Yield
-240.6%
Adj. FCF Yield
-250.6%

Financial Health

Net Cash
$5.43M
Total Debt
$0
Cash & Short-Term Investments
$5.43M
Total Assets
$5.95M
Current Ratio
5.36
Quick Ratio
5.36
Debt / Equity Ratio
0.00
Debt / EBITDA
-0.00
Debt / FCF
-0.00
OCF / Debt
N/A
Interest Coverage
-112.03
Altman Z-Score
-5.99
Piotroski F-Score
1

Margins & Profitability

Gross Profit Margin
-474.3%
Operating Profit Margin
-8250.5%
EBITDA Margin
-8473.3%
Net Profit Margin
-8269.5%
FCF Margin
-6176.8%
Adj. FCF Margin
-6433.4%
SBC / Revenue
256.6%
SBC Impact (per share)
-4.2%

Returns

Return on Assets
-75.1%
Return on Equity
-81.7%
Return on Invested Capital
-91.3%
Return on Capital Employed
-91.3%
Return on Tangible Assets
-77.9%

Historical Growth (CAGR)

Revenue CAGR 3Y
-9.1%
Revenue CAGR 5Y
-6.0%
Revenue CAGR 10Y
-15.0%
EPS CAGR 3Y
48.5%
EPS CAGR 5Y
-68.7%
EPS CAGR 10Y
-0.2%
FCF CAGR 3Y
2.6%
FCF CAGR 5Y
-8.4%
FCF CAGR 10Y
-27.0%

Analyst Forecasts

Analyst Rating
Hold
Analyst Count
0
EPS Growth Next 3Y
N/A
Revenue Growth Next 3Y
N/A
Earnings Date
Dec 2, 2026
EPS Estimate (next Q)
-$4.80
EPS Growth Est (next Q)
3900.0%
Revenue Est (next Q)
$18K
Revenue Growth Est (next Q)
-0.1%

Fair Value Estimates

Graham Number
N/A
Graham Upside
N/A
Lynch Fair Value
N/A
Lynch Upside
N/A
Price Target
$0.00
Price Target Upside
N/A

Cash Flow

Operating Cash Flow
$-3.34M
Free Cash Flow
$-3.34M
Adj. Free Cash Flow
$-3.48M
FCF Per Share
-$3.04
OCF Per Share
-$3.04
OCF/S Ratio
-6176.8%

Income Statement

Revenue
$54.08K
Gross Profit
$-256.5K
Operating Income
$-4.46M
EBITDA
$-4.58M
Net Income
$-4.47M
EPS (Diluted)
-$5.35
Revenue / Employee
$18.03K
Profit / Employee
$-1.49M
Employees
3

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.